168 related articles for article (PubMed ID: 11307045)
1. The effect of levodopa on vocal function in Parkinson's disease.
Sanabria J; Ruiz PG; Gutierrez R; Marquez F; Escobar P; Gentil M; Cenjor C
Clin Neuropharmacol; 2001; 24(2):99-102. PubMed ID: 11307045
[TBL] [Abstract][Full Text] [Related]
2. Glottographic measures before and after levodopa treatment in Parkinson's disease.
Jiang J; Lin E; Wang J; Hanson DG
Laryngoscope; 1999 Aug; 109(8):1287-94. PubMed ID: 10443835
[TBL] [Abstract][Full Text] [Related]
3. Impact of levodopa treatment in the voice pattern of Parkinson's disease patients: a systematic review and meta-analysis.
Pinho P; Monteiro L; Soares MFP; Tourinho L; Melo A; Nóbrega AC
Codas; 2018 Oct; 30(5):e20170200. PubMed ID: 30304100
[TBL] [Abstract][Full Text] [Related]
4. Orofacial Strength and Voice Quality as Outcome of Levodopa Challenge Test in Parkinson Disease.
Lechien JR; Delsaut B; Abderrakib A; Huet K; Delvaux V; Piccaluga M; Khalife M; Harmegnies B; Saussez S; Blecic S
Laryngoscope; 2020 Dec; 130(12):E896-E903. PubMed ID: 32239775
[TBL] [Abstract][Full Text] [Related]
5. Phonatory characteristics of parkinsonian speech before and after morning medication: the ON and OFF states.
Goberman A; Coelho C; Robb M
J Commun Disord; 2002; 35(3):217-39. PubMed ID: 12064785
[TBL] [Abstract][Full Text] [Related]
6. Voice Quality and Orofacial Strength as Outcome of Levodopa Effectiveness in Patients with Early Idiopathic Parkinson Disease: A Preliminary Report.
Lechien JR; Blecic S; Ghosez Y; Huet K; Harmegnies B; Saussez S
J Voice; 2019 Sep; 33(5):716-720. PubMed ID: 29724466
[TBL] [Abstract][Full Text] [Related]
7. Prosody and levodopa in Parkinson's disease.
Azevedo LL; Reis CA; Souza IS; Cardoso FE
Arq Neuropsiquiatr; 2013 Nov; 71(11):835-40. PubMed ID: 24394867
[TBL] [Abstract][Full Text] [Related]
8. Effects of bilateral subthalamic nucleus stimulation and medication on parkinsonian speech impairment.
D'Alatri L; Paludetti G; Contarino MF; Galla S; Marchese MR; Bentivoglio AR
J Voice; 2008 May; 22(3):365-72. PubMed ID: 17368837
[TBL] [Abstract][Full Text] [Related]
9. Voice quality severity and responsiveness to levodopa in Parkinson's disease.
Cushnie-Sparrow D; Adams S; Abeyesekera A; Pieterman M; Gilmore G; Jog M
J Commun Disord; 2018; 76():1-10. PubMed ID: 30053648
[TBL] [Abstract][Full Text] [Related]
10. Relationship Between Voice and Motor Disabilities of Parkinson's Disease.
Majdinasab F; Karkheiran S; Soltani M; Moradi N; Shahidi G
J Voice; 2016 Nov; 30(6):768.e17-768.e22. PubMed ID: 26725551
[TBL] [Abstract][Full Text] [Related]
11. [Speech and voice disorders in Parkinson's disease].
Martnez-Sánchez F
Rev Neurol; 2010 Nov; 51(9):542-50. PubMed ID: 20979034
[TBL] [Abstract][Full Text] [Related]
12. Correlation between acoustic speech characteristics and non-speech motor performance in Parkinson Disease.
Goberman AM
Med Sci Monit; 2005 Mar; 11(3):CR109-16. PubMed ID: 15735562
[TBL] [Abstract][Full Text] [Related]
13. Acoustic voice analysis in patients with Parkinson's disease treated with dopaminergic drugs.
Gamboa J; Jiménez-Jiménez FJ; Nieto A; Montojo J; Ortí-Pareja M; Molina JA; García-Albea E; Cobeta I
J Voice; 1997 Sep; 11(3):314-20. PubMed ID: 9297676
[TBL] [Abstract][Full Text] [Related]
14. Effects of levodopa on laryngeal muscle activity for voice onset and offset in Parkinson disease.
Gallena S; Smith PJ; Zeffiro T; Ludlow CL
J Speech Lang Hear Res; 2001 Dec; 44(6):1284-99. PubMed ID: 11776365
[TBL] [Abstract][Full Text] [Related]
15. For better or worse: The effect of levodopa on speech in Parkinson's disease.
Ho AK; Bradshaw JL; Iansek R
Mov Disord; 2008 Mar; 23(4):574-80. PubMed ID: 18163453
[TBL] [Abstract][Full Text] [Related]
16. Acoustic voice assessment in Parkinson's disease patients submitted to posteroventral pallidotomy.
Mourão LF; Aguiar PM; Ferraz FA; Behlau MS; Ferraz HB
Arq Neuropsiquiatr; 2005 Mar; 63(1):20-5. PubMed ID: 15830059
[TBL] [Abstract][Full Text] [Related]
17. Effects of Levodopa on Vowel Articulation in Patients with Parkinson's Disease.
Okada Y; Murata M; Toda T
Kobe J Med Sci; 2015 Apr; 61(5):E144-54. PubMed ID: 27363398
[TBL] [Abstract][Full Text] [Related]
18. Daily Phonatory Activity of Individuals With Parkinson's Disease.
Searl J; Dietsch AM
J Voice; 2024 May; 38(3):800.e13-800.e26. PubMed ID: 34819239
[TBL] [Abstract][Full Text] [Related]
19. [Acoustic analysis of prosody in females with Parkinson's disease: effect of L-dopa].
Azevedo LL; Cardoso F; Reis C
Arq Neuropsiquiatr; 2003 Dec; 61(4):995-8. PubMed ID: 14762605
[TBL] [Abstract][Full Text] [Related]
20. Vocal acoustic characteristics of patients with Parkinson's disease.
Tanaka Y; Nishio M; Niimi S
Folia Phoniatr Logop; 2011; 63(5):223-30. PubMed ID: 21212679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
